170 related articles for article (PubMed ID: 21565804)
21. Whole-genome pyrosequencing of an epidemic multidrug-resistant Acinetobacter baumannii strain belonging to the European clone II group.
Iacono M; Villa L; Fortini D; Bordoni R; Imperi F; Bonnal RJ; Sicheritz-Ponten T; De Bellis G; Visca P; Cassone A; Carattoli A
Antimicrob Agents Chemother; 2008 Jul; 52(7):2616-25. PubMed ID: 18411315
[TBL] [Abstract][Full Text] [Related]
22. Analysis of tigecycline resistance development in clinical Acinetobacter baumannii isolates through a combined genomic and transcriptomic approach.
Liu L; Cui Y; Zheng B; Jiang S; Yu W; Shen P; Ji J; Li L; Qin N; Xiao Y
Sci Rep; 2016 May; 6():26930. PubMed ID: 27240484
[TBL] [Abstract][Full Text] [Related]
23. New insights into dissemination and variation of the health care-associated pathogen Acinetobacter baumannii from genomic analysis.
Wright MS; Haft DH; Harkins DM; Perez F; Hujer KM; Bajaksouzian S; Benard MF; Jacobs MR; Bonomo RA; Adams MD
mBio; 2014 Jan; 5(1):e00963-13. PubMed ID: 24449752
[TBL] [Abstract][Full Text] [Related]
24. Role of insertion sequence Aba-1 and AdeS in reduced tigecycline susceptibility in MDR-Acinetobacter baumannii clinical isolates from Cairo, Egypt.
Hassan R; Mukhtar A; Hasanin A; Ghaith D
J Chemother; 2018 Apr; 30(2):89-94. PubMed ID: 29108486
[TBL] [Abstract][Full Text] [Related]
25. Unexpected tigecycline resistance among Acinetobacter baumannii Isolates: high minor error rate by Etest.
Kulah C; Celebi G; Aktas E; Mengeloglu Z; Comert F; Ankarali H
J Chemother; 2009 Aug; 21(4):390-5. PubMed ID: 19622456
[TBL] [Abstract][Full Text] [Related]
26. AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus-Acinetobacter baumannii complex.
Ruzin A; Keeney D; Bradford PA
J Antimicrob Chemother; 2007 May; 59(5):1001-4. PubMed ID: 17363424
[TBL] [Abstract][Full Text] [Related]
27. Phenotypic and WGS-derived antimicrobial resistance profiles of clinical and non-clinical Acinetobacter baumannii isolates from Germany and Vietnam.
Wareth G; Linde J; Hammer P; Nguyen NH; Nguyen TNM; Splettstoesser WD; Makarewicz O; Neubauer H; Sprague LD; Pletz MW
Int J Antimicrob Agents; 2020 Oct; 56(4):106127. PubMed ID: 32750418
[TBL] [Abstract][Full Text] [Related]
28. Amplification of aminoglycoside resistance gene aphA1 in Acinetobacter baumannii results in tobramycin therapy failure.
McGann P; Courvalin P; Snesrud E; Clifford RJ; Yoon EJ; Onmus-Leone F; Ong AC; Kwak YI; Grillot-Courvalin C; Lesho E; Waterman PE
mBio; 2014 Apr; 5(2):e00915. PubMed ID: 24757213
[TBL] [Abstract][Full Text] [Related]
29. Emergence of rifampicin, tigecycline, and colistin-resistant Acinetobacter baumannii in Iran; spreading of MDR strains of novel International Clone variants.
Bahador A; Taheri M; Pourakbari B; Hashemizadeh Z; Rostami H; Mansoori N; Raoofian R
Microb Drug Resist; 2013 Oct; 19(5):397-406. PubMed ID: 23768166
[TBL] [Abstract][Full Text] [Related]
30. Draft genome sequence of a multidrug-resistant OXA-23-producing Acinetobacter baumannii ST191 clinical isolate from China.
Xu J; Lin W; Xi W; Yao Y
J Glob Antimicrob Resist; 2017 Sep; 10():8-9. PubMed ID: 28572036
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Minocycline Susceptibility Testing Methods for Carbapenem-Resistant Acinetobacter baumannii.
Wang P; Bowler SL; Kantz SF; Mettus RT; Guo Y; McElheny CL; Doi Y
J Clin Microbiol; 2016 Dec; 54(12):2937-2941. PubMed ID: 27629901
[TBL] [Abstract][Full Text] [Related]
32. Changes in MIC within a global collection of Acinetobacter baumannii collected as part of the Tigecycline Evaluation and Surveillance Trial, 2004 to 2009.
Morfin-Otero R; Dowzicky MJ
Clin Ther; 2012 Jan; 34(1):101-12. PubMed ID: 22177546
[TBL] [Abstract][Full Text] [Related]
33. Genetic Variability of AdeRS Two-Component System Associated with Tigecycline Resistance in XDR-Acinetobacter baumannii Isolates.
Montaña S; Vilacoba E; Traglia GM; Almuzara M; Pennini M; Fernández A; Sucari A; Centrón D; Ramírez MS
Curr Microbiol; 2015 Jul; 71(1):76-82. PubMed ID: 25941024
[TBL] [Abstract][Full Text] [Related]
34. Mutant prevention concentration of tigecycline for carbapenem-susceptible and -resistant Acinetobacter baumannii.
Cui JC; Liu YN; Chen LA
J Antibiot (Tokyo); 2010 Jan; 63(1):29-31. PubMed ID: 19911030
[No Abstract] [Full Text] [Related]
35. Tigecycline treatment in an infant with extensively drug-resistant Acinetobacter baumannii bacteremia.
Zeng J; Zhang L; Gao M; Wu J; Wu H; Chen J; Chen X; Tang W
Int J Infect Dis; 2017 Aug; 61():23-26. PubMed ID: 28572073
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of the adeB gene in clinical isolates of tigecycline-nonsusceptible Acinetobacter baumannii without insertion mutations in adeRS.
Sun JR; Chan MC; Chang TY; Wang WY; Chiueh TS
Antimicrob Agents Chemother; 2010 Nov; 54(11):4934-8. PubMed ID: 20696871
[TBL] [Abstract][Full Text] [Related]
37. Outbreak Caused by blaOXA-72-Producing Acinetobacter baumannii ST417 Detected in Clinical and Environmental Isolates.
Tamayo-Legorreta E; Turrubiartes-Martínez E; Garza-Ramos U; Niño-Moreno P; Barrios H; Sánchez-Pérez A; Reyna-Flores F; Tovar-Oviedo J; Magaña-Aquino M; Cevallos MA; Silva-Sanchez J
Microb Drug Resist; 2016 Mar; 22(2):129-33. PubMed ID: 26954369
[TBL] [Abstract][Full Text] [Related]
38. Whole-Genome Analysis of an Extensive Drug-Resistant Acinetobacter Baumannii ST195 Isolate from a Recipient After DCD Renal Transplantation in China.
Jiang H; Cao L; Shen Q; Qu L; Jiang Y; Qu T; Zhang J; Lu Y; Li B; Zhu C; Liu G; Wang R; Chen M; Wang Y; Wang Y; Feng S; Wang J; Yu Y; Wu J; Chen J
Kidney Blood Press Res; 2017; 42(6):1247-1257. PubMed ID: 29248914
[TBL] [Abstract][Full Text] [Related]
39. Phenotypic and molecular characterization of Acinetobacter baumannii clinical isolates from nosocomial outbreaks in Los Angeles County, California.
Valentine SC; Contreras D; Tan S; Real LJ; Chu S; Xu HH
J Clin Microbiol; 2008 Aug; 46(8):2499-507. PubMed ID: 18524965
[TBL] [Abstract][Full Text] [Related]
40. Tigecycline in carbapenem-resistant Acinetobacter baumannii bacteraemia: susceptibility and clinical outcome.
Kim NH; Hwang JH; Song KH; Choe PG; Kim ES; Park SW; Kim HB; Kim NJ; Park WB; Oh MD
Scand J Infect Dis; 2013 Apr; 45(4):315-9. PubMed ID: 23113680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
